Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, announced that shareholders approved all proposals put forward by the Board of Directors at its Annual General Meeting (AGM), held earlier today via live webcast. This includes the payment of a gross dividend of 0.35 CHF per dividend-bearing share1, to be distributed out of reserves from capital contributions.
Shareholders approved the election of Harry Kirsch as independent member of the Board of Directors, as well as the election of Samuel du Retail and Delphine Viguier-Hovasse, representatives of L’Oréal, as non-independent members of the Board. In addition, Thomas Ebeling (Chair), Daniel Browne, Maria Teresa Hilado, Karen Lee Ling, Roberto Marques, Sherilyn McCoy and Dr. Flemming Ørnskov were re-elected to the Board.
The AGM also approved the company’s 2025 Annual Financial Statements, Non-Financial Report and Compensation Report.
Detailed voting results and the official minutes will be published on Galderma's Investor Relations website (https://investors.galderma.com) within the next two weeks.
About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.
1 In accordance with applicable tax regulations and in application of Art. 5 para. 1ter of the Swiss Act on Withholding Tax, 100% of the dividend paid out of reserves from capital contributions will be free from Swiss withholding tax.
-
探秘宫廷膏方,溯源国药匠心,御君方举办五仙膏溯源活动,让每一份信任都有归处探秘宫廷膏方,溯源国药匠心,御君方举办五仙膏溯源活动,让每一份信任都有归处2026-04-23
-
御君方溯源五仙膏生产车间,溯的不仅是产品更是初心,是从根上正本清源御君方溯源五仙膏生产车间,溯的不仅是产品更是初心,是从根上正本清源2026-04-23
-
Galderma Shareholders Approve All Annual General Meeting ProposalsGalderma Group AG (SIX:GALD), the pure-play dermatology category leader, announced that shareholders approved all proposals put forward by the Board o2026-04-23
-
Chatham Financial 拟收购 Hodes Weill & Associates,为实物资产管理机构提供一体化资本市场解决方案Chatham Financial(以下简称“Chatham”)作为领先的独立资本市场顾问机构,凭借专业咨询能力与先进技术,持续帮助各类组织降低风险并把握发展机遇。公司今日宣布,已就收2026-04-23
-
SBC Medical宣布已完成此前公布的310万股普通股二次公开发行SBC Medical Group Holdings Incorporated(Nasdaq:SBC)(简称“公司”)是一家管理服务机构,在多个医疗领域运营各类特许经营业务。该公司今日宣布此前公告的由Yoshiyuki2026-04-23
-
AMD股价暴跌17%创近9年之最,苏姿丰紧急回应:AI增速远超想象
-
江苏省脑机接口产业联盟在宁成立,麦澜德分享前沿成果
-
艾芬达入选国家知识产权强国建设示范创建对象:二十载长期主义,兑现每一份用户价值
-
慧启赣疆 聚势共赢丨慧友酒店集团江西品鉴会书写区域文旅融合新篇
-
电影《一秒》定档:2026年,活在这一秒
-
西藏斜视患儿寒假进京手术成功,千里护航点亮视觉未来
-
年度盛典|卓兴半导体2025年度总结表彰暨 2026 年迎新晚会
-
科技赋能 生态协同,登途集团车辆资产管理运营模式助推行业提质增效
-
公元地暖构建“产品+施工+服务”全维保障网,兑现50年温暖承诺
-
VCI Global 投资组合公司 Reveillon Group 与 NOWWA Coffee 达成战略合作,共同开拓马来西亚市场
